Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2025-12-26 @ 1:28 AM
Study NCT ID:
NCT03557333
Status:
COMPLETED
Last Update Posted:
2021-03-11
First Post:
2018-06-04
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Safety and Tolerability of POD-DHE (INP104) in Migraine (STOP 301)
Sponsor:
Impel Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-13
Start Date Type:
ACTUAL
Primary Completion Date:
2020-03-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-03-17
Completion Date Type:
ACTUAL
First Submit Date:
2018-06-04
First Submit QC Date:
None
Study First Post Date:
2018-06-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-01-26
Results First Submit QC Date:
None
Results First Post Date:
2021-02-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-12
Last Update Post Date:
2021-03-11
Last Update Post Date Type:
ACTUAL